Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

MAN2B1 Inhibitors

MAN2B1, also known as alpha-mannosidase II, is an enzyme that plays a crucial role in the modification of N-linked oligosaccharides during glycoprotein biosynthesis. The process of glycosylation, where sugar moieties are attached to proteins, is fundamental for proper protein folding, stability, and cell signaling. MAN2B1 specifically functions in the Golgi apparatus, where it catalyzes the hydrolysis of the terminal alpha-mannose residues from the intermediate oligosaccharide in a precise sequence that ensures the correct glycan structure. Given its key position in the glycosylation pathway, the expression and activity of MAN2B1 are tightly regulated within the cellular environment. Alterations in the expression of MAN2B1 can have significant effects on the glycosylation pattern of proteins, impacting a broad range of cellular functions and the physiological state of the organism.In the exploration of MAN2B1 expression, researchers have identified several chemical compounds that could potentially serve as inhibitors, influencing the expression level of this enzyme. Compounds such as 5-Azacytidine and Decitabine may inhibit expression by causing DNA demethylation at the gene promoter, leading to transcriptional repression. Histone deacetylase inhibitors like Trichostatin A and Vorinostat are known to alter chromatin structure, which can result in decreased MAN2B1 gene transcription. Other compounds, such as Mithramycin A, could directly interfere with transcription factor binding to the MAN2B1 promoter, thus reducing expression. Sirolimus, an inhibitor of the mTOR pathway, may decrease the translation of MAN2B1 transcripts, while LY294002, a PI3K inhibitor, could suppress downstream signaling pathways essential for the transcription of the MAN2B1 gene. Curcumin, with its broad-spectrum influence on transcription factors, might lead to a reduction in MAN2B1 mRNA synthesis, demonstrating the diverse mechanisms through which chemical compounds can exert their effects on this critical enzyme's expression. These findings provide a basis for further research into the complex regulation of MAN2B1 and highlight the intricate interplay between chemical compounds and genetic expression.

Items 1 to 10 of 13 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Swainsonine

72741-87-8sc-201362
sc-201362C
sc-201362A
sc-201362D
sc-201362B
1 mg
2 mg
5 mg
10 mg
25 mg
$138.00
$251.00
$631.00
$815.00
$1832.00
6
(1)

Swainsonine acts as a selective inhibitor of the MAN2B1 enzyme, impacting the hydrolysis of mannose-rich oligosaccharides. Its unique stereochemistry facilitates strong binding to the enzyme's active site, leading to altered kinetic parameters and substrate specificity. This interaction disrupts normal glycan degradation pathways, influencing cellular glycoprotein turnover and potentially affecting various cellular processes, including adhesion and recognition mechanisms.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine, through its incorporation into DNA, could lead to the hypomethylation of the MAN2B1 gene promoter, resulting in its decreased transcription.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A may directly inhibit histone deacetylase activity, leading to hyperacetylation of histones associated with the MAN2B1 gene, potentially resulting in transcriptional repression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

5-Aza-2′-Deoxycytidine (Decitabine) can be integrated into DNA and subsequently inhibit DNA methyltransferases, which may result in the demethylation and silencing of the MAN2B1 gene.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid's inhibition of histone deacetylases could lead to alterations in chromatin structure around the MAN2B1 gene, potentially leading to a decrease in its expression levels.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

MS-275 (Entinostat) may cause specific hypoacetylation of histones at the MAN2B1 gene locus, which can lead to a more condensed chromatin state and decreased gene expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A, by binding to DNA, could competitively inhibit the binding of transcription factors to the promoter of the MAN2B1 gene, leading to decreased transcription.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid could activate nuclear hormone receptors that bind to retinoic acid response elements in the MAN2B1 gene promoter, resulting in downregulated gene expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin's inhibition of the mTOR signaling pathway may lead to a downregulation of MAN2B1 expression by decreasing the translation of its mRNA into protein.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002's inhibition of PI3K could lead to a reduction in the downstream signaling required for the transcription of the MAN2B1 gene, thereby reducing its expression.